Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers... Show more
Cardinal Health, Inc. (CAH), a leading pharmaceutical distributor and medical product manufacturer, pays a quarterly dividend of $0.5107 per share, resulting in an annual payout of $2.04 and a current yield of about 1.0%. The most recent ex-dividend date was April 1, 2026, with payment on April 15, 2026. This positions CAH as a modest dividend stock rather than a high-yield play, appealing to investors seeking stability over aggressive income. With a history of consistent payments since 1985, it exemplifies a reliable dividend profile in the healthcare distribution sector.
Cardinal Health has a robust dividend history spanning nearly four decades, earning its status as a Dividend Aristocrat with approximately 40 consecutive years of annual increases. Recent quarterly dividends have risen steadily: from $0.5006 in early 2024 to $0.5056 in 2025, and $0.5107 since mid-2025. Earlier examples include $0.4957 in 2023 and $0.4908 in 2022, reflecting annual adjustments amid stable operations. No recent cuts have occurred, underscoring a long-term strategy of gradual growth tied to earnings expansion in pharmaceutical distribution and medical solutions.
The dividend's sustainability is bolstered by a payout ratio of 29-30%, well below 50%, meaning only a fraction of earnings is distributed, leaving ample room for reinvestment and resilience. Earnings per share comfortably cover the payout, with recent figures around $6.99 supporting the $2.04 annual dividend. Free cash flow (FCF), at $1.85 billion in fiscal 2025, provides strong coverage despite sector pressures. Moderate debt levels and consistent operating cash flow generation further affirm financial stability, positioning the dividend as secure even in volatile healthcare markets.
In the healthcare distribution industry, CAH's 1.0% yield stands out as competitive. Peer MCK (McKesson) yields about 0.4%, while COR (Cencora) offers 0.8%. HSIC (Henry Schein) currently pays no dividend. CAH's higher yield, combined with its Dividend Aristocrat status, makes it relatively attractive for income within a sector favoring growth over payouts.
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. It efficiently identifies dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities. Explore the AI Screener to streamline your research today.
Cardinal Health appeals to conservative dividend growth investors who prioritize longevity and stability over high yields. Its 40-year streak of increases and low payout ratio suit those building long-term portfolios in defensive sectors like healthcare. Income-focused investors may find the 1% yield modest compared to utilities or REITs, but the coverage by earnings and FCF offers reassurance amid opioid litigation risks and supply chain dynamics. For dividend enthusiasts valuing Aristocrat pedigree, CAH provides a balanced option, though total returns have been driven more by share appreciation. Balanced portfolios might allocate modestly, weighing sector exposure against reliable quarterly payouts.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
a maker of pharmaceuticals, medical, surgical and laboratory supplies as well as develops drug delivery systems
Industry MedicalDistributors